1. Yan, Jinhua, Wu, Jinzheng, Wang, Yang, Li, Duo, Zhang, Shubing. 2023. A novel RBBP8(p.E281*) germline mutation is a predisposing mutation in familial hereditary cancer syndrome. In Journal of molecular medicine (Berlin, Germany), 101, 1255-1265. doi:10.1007/s00109-023-02354-z. https://pubmed.ncbi.nlm.nih.gov/37615686/
2. Zhang, Weilong, Song, Ying, He, Xue, Yuan, Xiaoliang, Jing, Hongmei. 2019. Prognosis value of RBBP8 expression in plasma cell myeloma. In Cancer gene therapy, 27, 22-29. doi:10.1038/s41417-018-0069-3. https://pubmed.ncbi.nlm.nih.gov/30622325/
3. Liu, Zhendong, Cheng, Xingbo, Lin, Shaochong, Qian, Rongjun, Gao, Yanzheng. 2022. Prognostic Significance of mRNA Expression RBBP8 or Its Methylation in Gliomas. In Cellular and molecular neurobiology, 43, 409-422. doi:10.1007/s10571-022-01198-4. https://pubmed.ncbi.nlm.nih.gov/35106666/
4. Yu, Yang, Chen, Lei, Zhao, Guiping, Min, Li, Zhang, Shutian. 2019. RBBP8/CtIP suppresses P21 expression by interacting with CtBP and BRCA1 in gastric cancer. In Oncogene, 39, 1273-1289. doi:10.1038/s41388-019-1060-7. https://pubmed.ncbi.nlm.nih.gov/31636387/
5. Zarrizi, Reihaneh, Higgs, Martin R, Voßgröne, Karolin, Nielsen, Finn Cilius, Sørensen, Claus S. . Germline RBBP8 variants associated with early-onset breast cancer compromise replication fork stability. In The Journal of clinical investigation, 130, 4069-4080. doi:10.1172/JCI127521. https://pubmed.ncbi.nlm.nih.gov/32379725/
6. Zhou, Zeyi, Liu, Yan, Gao, Shijuan, Du, Jie, Wang, Dongjin. 2021. Excessive DNA damage mediates ECM degradation via the RBBP8/NOTCH1 pathway in sporadic aortic dissection. In Biochimica et biophysica acta. Molecular basis of disease, 1868, 166303. doi:10.1016/j.bbadis.2021.166303. https://pubmed.ncbi.nlm.nih.gov/34780912/
智鼠故事 
